![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
North America's Largest Meta-Analysis on
the Prevalence of NAFLD, NASH, and Advanced Fibrosis (F3-F4)
|
|
|
AASLD 2020 Nov 11-16
Ahmed A1, Espinueva AA2, Bam RA2, Lu K2, Wang L2, Wang Y2, Ferrinho D2, Jia C2, Juneja K2, Bambha K3
1Division of Gastroenterology and Hepatology, Stanford University, Stanford, CA; 2Gilead Sciences, Inc., Foster City, CA; 3Division of Gastroenterology and Hepatology, University of Washington, Seattle, WA
![1124201](../images/112420/112420-6/1124201.gif)
![1124202](../images/112420/112420-6/1124202.gif)
![1124203](../images/112420/112420-6/1124203.gif)
![1124204](../images/112420/112420-6/1124204.gif)
![1124205](../images/112420/112420-6/1124205.gif)
![1124206](../images/112420/112420-6/1124206.gif)
![1124207](../images/112420/112420-6/1124207.gif)
References: 1. Chalasani N. et al. Hepatology: 2018;328-357; 2. Dulai P, et al. Hepatology. 2017;65(5):1557-1565; 3. Maximos, et al. Hepatol. 2105;61:153-160
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|